The Harm Reduction Learning Institute – reduceharmdc.org – offers providers, community leaders, and other harm reductionists free education and training covering key topics from naloxone administration and overdose response to stigma reduction and community outreach.
Your Online Resource for Harm Reduction Education and Training
The Institute features a comprehensive substantive curriculum designed to address the complex challenges surrounding substance use. These courses offer comprehensive, innovative insights and evidence-based practices that reflect the evolving landscape of harm reduction, including:
- Harm reduction strategies for diverse populations,
- Facilitating a healthy and productive patient-provider relationship, and
- Opioid use and how to prevent or treat overdoses.
DC Engage Harm Reduction Conference
Thursday, April 11, 2024
This day-long, in-person conference will engage clinicians, service providers, and community members in harm reduction prevention, treatment, and recovery strategies.
The conference is free to attend and some of the sessions will include free continuing education credits.
Patient-Provider Relationship in Addressing Addiction
This module details effective patient-provider communication in addressing opioid use, misuse, and abuse. It identifies and describes models of communication, applying relevant content to the process of addressing opioid use disorders and the concern of stigma in clinical practice.
Opioid Overdose Prevention & Naloxone Education for Community
This module is intended for public use. By completing this module, learners will be able to utilize nasal naloxone to reverse a known overdose in emergency situations. Learners will understand how nasal naloxone reverses an overdose and will be able to summarize the epidemiology of opioid overdoses in the District of Columbia.
Beyond Borders: Mapping HCV Care Challenges in DC and Across the Nation
This module provides a comprehensive exploration of hepatitis C (HCV) transmission, prevention, and treatment. Participants will review demographics of high-risk populations, learn about the revolutionary impact of direct-acting antivirals (DAAs), and evaluate strategies for universal HCV testing in reducing transmission rates and improving public health outcomes.
Community Mapping and Identifying Priority Populations for HIV Prevention and Care
This 2023 Community Mapping Toolkit for D.C. Organizations details how visualizing health disparities can help outreach programs for HIV prevention. The toolkit explores how community mapping can support your work, what goes into creating a community map, and how to use mapping tools that are available online.
TIP 63: Medications for Opioid Use Disorder
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
The Opioid Crisis and the Black/African American Population: An Urgent Issue
This issue brief presents recent data on prevalence of opioid misuse and death rates in the Black/AA population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.